Bowel obstruction in patients with ovarian carcinoma: analysis of prognostic factors.

Gynecologic Oncology
J E LarsonR Mortel

Abstract

A retrospective study was performed in which patients with both bowel obstruction and ovarian carcinoma admitted to the gynecologic oncology service at the Milton S. Hershey Medical Center between July 1, 1980, and June 30, 1987, were examined. Thirty-three patients were identified who fulfilled the inclusion criteria for bowel obstruction that did not occur in the postoperative period. Historical, physical, nutritional, and laboratory variables thought to contribute to patient survival were evaluated by a retrospective chart review. Survival time was not significantly related to presence or absence of tumor at obstruction, type of intervention whether medical or surgical, patient age, or interval from initial diagnosis of ovarian cancer to obstruction. Survival time was found to be significantly related to the prognostic index initially proposed by H. B. Krebs and D. R. Goplerud [Obstet. Gynecol. 61, 327-330 (1983)], P = 0.002. This prognostic index incorporates a multifactorial assessment of patient status including age, nutritional status, tumor spread, ascites, and prior chemotherapy and radiotherapy and can be used to evaluate patients at the time of presentation with intestinal obstruction and to help select optimal treat...Continue Reading

References

Feb 1, 1988·American Journal of Obstetrics and Gynecology·J R FernandesS Suissa
Jul 15, 1985·American Journal of Obstetrics and Gynecology·B F Helmkamp, J Kimmel
Feb 1, 1970·Cancer·A S KetchamD L Morton
Feb 1, 1982·Gynecologic Oncology·M S PiverA Frank
Oct 1, 1981·Gynecologic Oncology·J C TuncaW F Carr

❮ Previous
Next ❯

Citations

Jul 1, 1994·Seminars in Surgical Oncology·R Farias-EisnerJ S Berek
Apr 26, 2003·Gynecologic Oncology·Bhavana PothuriDennis S Chi
Sep 10, 2002·The Lancet Oncology·Mark Harries, Martin Gore
Apr 27, 2002·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Carla Ripamonti, Eduardo Bruera
Apr 30, 2005·Journal of Palliative Medicine·P Rousseau
Sep 24, 1999·British Journal of Obstetrics and Gynaecology·E TsahalinaD P Barton
Sep 22, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·G MangiliA Ferrari
Feb 1, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·D N BryanJ S Berek
Jan 10, 2013·The Oncologist·Joanie Mayer Hope, Bhavana Pothuri
Nov 26, 2013·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·T PerriD Rosin
Feb 16, 2010·Gynecologic Oncology·Edward J TannerRobert E Bristow
Apr 1, 1994·Journal of Pain and Symptom Management·C Ripamonti
Mar 26, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Alberto DanieleG Menato
Jan 1, 2013·Gynecologic Oncology·Stephen J MooneyAlfred I Neugut
Dec 23, 2014·Journal of Vascular and Interventional Radiology : JVIR·Sanjit O TewariRaymond H Thornton
Dec 29, 2010·The American Journal of Hospice & Palliative Care·Youssef RezkHoward S Smith
Jul 9, 2010·The Cochrane Database of Systematic Reviews·Ali KucukmetinHeather O Dickinson
Sep 13, 2013·The Cochrane Database of Systematic Reviews·Hazel A BillsonSorrel Burden
Mar 5, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Enrico SartoriTiziano Maggino
Jan 5, 2016·The Cochrane Database of Systematic Reviews·Sarah E CousinsDavid J Feuer
Feb 18, 2011·Current Opinion in Supportive and Palliative Care·Desiree F Kolomainen, Desmond P J Barton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
F A ZoetmulderA A Hart
© 2022 Meta ULC. All rights reserved